
A tweet by Sen. Bernie SandersBernie SandersOn The Money: Democrats deals to bolster support for relief bill | Biden tries to keep Democrats together | Retailers fear a return of the mask wars Democrats cut deals to bolster support for relief bill Hillicon Valley: High alert as new QAnon date approaches Thursday | Biden signals another reversal from Trump with national security guidance | Parler files a new case MORE (I-Vt.) sent a pharmaceutical company’s stock reeling on Tuesday.
Eli Lilly's stock dropped nearly 2 percentage points after Sanders criticized the rising price of the company's Humalog brand insulin, citing a Washington Post report on soaring costs of the diabetes drug.
Why has the price of Humalog insulin gone up 700% in 20 years? It's simple. The drug industry's greed. pic.twitter.com/SUeSbsr2Ka
— Bernie Sanders (@SenSanders) November 1, 2016
Biological technology stocks have been sinking as Election Day nears, out of concerns over Democratic presidential nominee Hillary ClintonHillary Diane Rodham ClintonHere's who Biden is now considering for budget chief Clinton praises Dolly Parton's cold shoulder top from vaccination: 'Shall we make this a trend?' Trump was unhinged and unchanged at CPAC MORE’s emphasis on cracking down on rising drug prices.